Skip to main content

Center Scholars

Training is one of the most vital missions of our Center, and our Center Scholars represent the future leaders of the field.

Our Scholars are a group of trainees and early-career professionals whose research interests and goals align with those of the CDSE.

If you are a master's or doctoral student or a clinical fellow and you are interested in becoming a Center Scholar, please contact us.

Current Center Scholars

Carissa White Dukes, MPH

Degree Program: DrPH
Advisor: Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Precision Psychiatry

Carissa White Dukes is a DrPH student pursuing the custom concentration track with a focus in pharmacoepidemiology and mental health. She is a dedicated pharmacoepidemiologist having worked in industry since graduating from Indiana University Richard Fairbanks School of Public Health with her Master of Public Health (MPH) degree in 2015. She has a passion for improving mental health outcomes through rigorous research and data analysis and is driven by the potential of pharmacoepidemiology to inform and improve psychiatric drug safety and efficacy. In her current role she analyzes large-scale patient data to understand patient populations, identify trends, risks, and opportunities for precision medicine in mental health. She is committed to advancing the understanding of mental health conditions and the factors that influence their prevalence, treatment, and outcomes. Her research efforts have spanned a wide range of topics, from investigating the safety and efficacy of psychotropic medications to examining the impact of social determinants on mental health disparities.  With a Doctor of Public Health (DrPH) degree, she hopes to gain the academic background and practical experience necessary to tackle complex issues at the intersection of pharmaceuticals and epidemiology in mental health. She also plans to use her acquired skills to contribute to the advancement of precision psychiatry for improved outcomes.

Joseph Hwang, MD, MSc

Degree Program: Postdoctoral Fellow
Advisors: Caleb Alexander, MD, MS & Todd Fojo, MD, MHS
Research Focus: Pharmacoepidemiology, Diabetes, HIV

Joseph Hwang is a general internal medicine fellow at the Johns Hopkins University School of Medicine. He completed his M.D. at Case Western Reserve University School of Medicine and internal medicine residency at the University of Pittsburgh Medical Center. He also received M.Sc. in epidemiology and has studied prescription drugs and health outcomes in chronic diseases. His research interests include pharmacoepidemiology, diabetes, and HIV.

Corey Joseph

Corey Joseph, MPH

Degree program: PhD (Epidemiology)
Advisor: G. Caleb Alexander, MD, MS
Research Focus: Causal inference and machine learning applications to pharmacoepidemiology

Corey Joseph is a PhD student in the Department of Epidemiology. Over the past three years, he led global evidence generation activities for the approval and reimbursement of pharmaceutical drugs in the ophthalmology, gastroenterology, and oncology therapeutic areas at Takeda Pharmaceuticals. Before Takeda, Corey held roles of increasing responsibility in the real world evidence group at IQVIA, and in the upper aerodigestive oncology group at the Johns Hopkins University School of Medicine. He obtained his MPH from the Boston University School of Public Health and his Bachelors of Science in Public and Community Health from the University of Maryland. His research interests are in the intersection of causal inference and machine learning methodologies.

 

Michael Kennedy

Michael Kennedy, PharmD

Degree Program: MPH
Advisor: Caleb Alexander, MD, MS
Research Interests: Pharmacoepidemiology, Addiction and Overdose in Community Pharmacy Settings

Michael is currently a part-time MPH student and a Bloomberg American Health Initiative Fellow, with a focus area in Addiction and Overdose.  He has spent most of his career as a pharmacist for CVS Health in the Detroit area.  Most recently, Michael has transitioned to a pharmacy advisor within their corporate office, working with a product development team in pharmacy operations.  In this role he helps research, develop, and implement new programs and initiatives with an aim to achieve better health outcomes for patients and communities. His research interests include pharmocoepidemiology and health behaviors as they relate to expanding the role of the community pharmacist in identifying and preventing addiction and overdose. 

 

Banda Abdallah A Khalifa

Banda A Khalifa, MD, MH, MBA

Degree Program: PhD (Epidemiology)
Advisor:  G. Caleb Alexander, MD, MS
Research Interest: Vaccine science policy and pharmaceutical outcomes and effectiveness

Dr. Banda Khalifa is an award-winning physician and a doctoral (Ph.D.) student in the department of epidemiology who works as a vaccine regulatory and policy analyst at the Johns Hopkins International Vaccine Access Center (IVAC).  He was an MPH & MBA Johns Hopkins Sommer Scholar and a Center Scholar focused on epidemiology and biostatistics with a certificate in Pharmacoepidemiology from 2018 to 2020. His MBA emphasis was in health systems, finance, and management, and he graduated as a Beta Gamma Sigma (International Business Honor Society) member. Dr. Banda has led and managed teams in government and non-governmental organizations through transformations that resulted in the organization's go-big objective being realized. He joined the Ghana Armed Forces in 2014 and won the Chief of the Defense Staff Award by Ghana's president after commissioning as the overall best graduating cadet. He led the medical team for Ghana's Aviation team on four UN Peacekeeping missions. Dr. Banda worked as a manager for the Covid-19 response program within the Baltimore City Health Department.  Dr. Banda formerly served as the vaccine and health delivery advisor for the Tony Blair Institute for Global Change. Dr. Banda received the 2022 alum impact award at the University of Ghana School of Medicine and Dentistry's 60th-anniversary celebration. His research interests include vaccination science policy, effectiveness, and outcomes research.

 

Randall Kuffel, ScM

DEGREE PROGRAM: PHD (EPIDEMIOLOGY)
ADVISOR: HEMALKUMAR MEHTA, PHD
RESEARCH FOCUS: PHARMACOEPIDEMIOLOGY, CLINICAL DECISION-MAKING

Randall Kuffel is a PhD student in the Department of Epidemiology. Prior to joining BSPH, he worked as a research associate at the San Francisco VA Health Care System in the Department of Psychiatry. His research has focused on the epidemiology of late-life suicide in the US veteran population, with emphases on antipsychotic medications, frailty, and PTSD.

Aster Meche, MPH

Aster Meche, MPH

Degree Program: PhD (Epidemiology)
Advisor: John Jackson, ScD & G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, drug utilization

Aster Meche is a PhD student in the Department of Epidemiology. For the past four years, she worked at Pfizer Inc where she supported real-world evidence generation activities for pharmaceutical drugs in development and post approval, specifically in oncology and inflammation and immunology therapeutic areas. Aster obtained her MPH from Columbia University Mailman School of Public Health and her Bachelors of Science in Public Health Sciences from University of California, Irvine. Her research interests include measures of quality of care, pharmacy access, utilization to medications, and treatment effectiveness.

 

Lijuan

Lijuan Zeng, MHS

Degree Program: PhD (Epidemiology)
Advisors: Stephan Ehrhardt, MD & Sheriza Baksh, PhD
Research Focus: Design and conduct of clinical trials, benefit-risk assessment, pharmacoepidemiology

Lijuan Zeng is a PhD student in Epidemiology. She previously worked at Statistics Collaborative, Inc. for several years as a biostatistician, providing statistical services regarding study designs and analyses of clinical research to pharmaceutical and biotech companies. She also served as an independent reporting statistician for Data and Safety Monitoring Boards for mainly industry-sponsored phases 2 and 3 clinical trials. Lijuan obtained her MHS in Epidemiology from Johns Hopkins Bloomberg School of Public Health and her Bachelor of Science in Pharmaceutical Science from Fudan University. Her research interest includes design and conduct of clinical trials, benefit-risk assessments, and pharmacoepidemiology.

 

Jinqi Zhan, MPH

DEGREE PROGRAM: PHD (EPIDEMIOLOGY)
ADVISORS: Douglas A. Jabs, M.D., M.B.A., M.S. & Ann Margret Ervin, Ph.D., MPH.
RESEARCH FOCUS: ADAPTIVE DESIGN CLINICAL TRIALS, REGULATORY SCIENCE

Jinqi Zhan is a Ph.D. student in the Clinical Trials and Evidence Synthesis Track at the Department of Epidemiology. She completed her MPH (Chronic Disease Epidemiology) at Yale University and worked in a biotech company for several years before starting her doctoral training. She gained experience in clinical trial regulatory submissions, Institutional Review Board applications, data monitoring, and patient recruitment in the US and Asia through executing an international oncology trial. For her future research, she hopes to explore adaptive design clinical trials, precision medicine, and regulatory science in cancer drug development. 

Elizabeth Szymanski

DEGREE PROGRAM: MHS
ADVISOR: Dr. Ann-Margret Ervin, MPH,PHD
RESEARCH FOCUS: PHARMACOEPIDEMIOLOGY, REAL-WORLD EVIDENCE, AND PATIENT ADVOCACY

Elizabeth Szymanski is an MHS candidate in the Epidemiology Department, specializing in Clinical Trials and Evidence Synthesis. She completed a BA in Neuroscience at Oberlin College, Ohio, with a focus on psychopharmacology, addiction science, and cognitive science. Prior to her time at Johns Hopkins, she worked as a Scientific Content Specialist for a life science and healthcare marketing agency. She conducted biostatistics research in genomic neurobiology at the University of Michigan School of Public Health and served as a research associate for the Cognitive Development Laboratory at the University of California, San Diego. She is interested in pharmacoepidemiology, real-world evidence, and patient advocacy.

Xinyi Sun

DEGREE PROGRAM: MHS (EPIDEMIOLOGY)
ADVISOR: Hemalkumar B. Mehta, PhD
RESEARCH FOCUS: PHARMACOEPIDEMIOLOGY, CAUSAL INFERENCE

Xinyi Sun earned her Bachelor Degree of Medicine with a major in Public Health from Sun Yat-sen University, China. Throughout her undergraduate study, she gained valuable knowledge and skills in epidemiological research and data analysis. Her bachelor’s degree thesis focused on studying the effects of switching ART regimens on renal function among people living with HIV. She is currently pursuing her MHS degree in Epidemiology, where her focus lies in causal inference methodology. Her specific interest extends to the application of these methods in pharmacoepidemiology.

Qilin Deng

DEGREE PROGRAM: MHS (EPIDEMIOLOGY)
ADVISORS: G. CALEB ALEXANDER, MD, MS
RESEARCH FOCUS: PHARMACOEPIDEMIOLOGY, HEALTHY LIFESTYLE INTERVENTIONS

Qilin Deng is an MHS student at Johns Hopkins Bloomberg School of Public Health, focusing on epidemiology with a keen interest in pharmacoepidemiology and the impact of lifestyle on diseases. Before joining Hopkins, Qilin earned a Bachelor of Medicine, specializing in Preventive Medicine. Her future research interests include delving into more real-world evidence, conducting benefit-risk assessments, and engaging in pharmacoepidemiology.

Honest Anaba

DEGREE PROGRAM: MPH
RESEARCH INTERESTS: SUBSTANCE USE EPIDEMIOLOGY, PHARMACOEPIDEMIOLOGY, HARM REDUCTION

Dr. Honest Anaba is a certified Addiction Medicine Physician and full-time MPH student. He is the first practising physician within West Africa to achieve certification from the International Society of Addiction Medicine (ISAM). He translates evidence-based treatment programs into patient care for diverse populations in his region. Beyond his clinical practice, he actively participates in educational, advocacy, and community engagement efforts to enhance addiction treatment and prevention.

Dr Anaba brings particular expertise in behavioural addictions and is a certified co-occurring Gambling specialist. His contributions span beyond the West African landscape. He leads research projects and subcommittee initiatives for ISAM's New Professionals Exploration, Training & Education. He is part of the ISAM Global Expert Network developing telemedicine protocols for Medication for Opioid Use Disorder (TMOUD). He is a peer reviewer for the Journal of Clinical Psychiatry and serves on the Anti-Racism, Diversity, Equity, and Inclusion committee at the American College of Academic Addiction Medicine.

Hsiu-Yi Liao

Degree Program: MPH
Research Interests: Pharmacoepidemiology and drug safety, effectiveness and utilization

Hsiu-Yi earned her Bachelor degree of Science with a major in Nursing from National Cheng Kung University in Taiwan and is currently pursuing an MPH degree at Johns Hopkins Bloomberg School of Public Health. Prior to her time at Hopkins, she worked as a registered nurse in a hospice ward and gained internship experience in drug development using AI technology. 

Sissi Jingjing Sun, DrPH, MHS, MSc, MBA

Degree Program: Postdoctoral Fellow
Advisors: Jodi Segal, MD, MPH & Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Drug Safety and Effectiveness, Real-World Evidence (RWE), Clinical Trials, Regulatory Science, and Health Economics and Outcomes Research (HEOR)

Dr. Sun received her DrPH and MHS from the Johns Hopkins Bloomberg School of Public Health, an MSc from the Johns Hopkins Carey Business School, and an MBA from the University of Hong Kong. With over a decade of experience in the medical industry, including roles in pharmaceutical marketing and strategic development for medical devices, she has gained extensive practical knowledge in drug safety and efficacy, particularly in ophthalmological, cardiovascular, and respiratory diseases. Shifting her career focus from China to the U.S. and global markets, she is now specializing in pharmacoepidemiology.

Her research interests stem from her industry experience, where she witnessed the complexities of ensuring drug safety and efficacy across diverse markets. Dr. Sun aims to investigate the utilization, effectiveness, and safety of medications and medical devices, with a strong emphasis on real-world evidence to mitigate risks associated with pharmaceutical treatments. Her research interests include examining the use of medicines to treat heart, lung, and blood diseases in the United States. She is committed to applying her expertise to improve patient outcomes and quality of life.

Ellen Barnie Peprah, MD

Degree Program: MPH/MBA

Ellen Peprah is a dual MPH/MBA student at Johns Hopkins University on the Health, Technology and Innovation pathway. After working in rural and urban Ghana as a medical doctor and experiencing the limited treatment options available for patients, she pivoted into public health to address systemic healthcare challenges. 

Prior to graduate school, she worked as a researcher at the NIHR Global Health Research Center for Non-Communicable Diseases and served as CYHN coordinator at the Commonwealth Secretariat. Her professional interests include clinical development, regulatory affairs, and patient safety, aligning with her goal of a career in pharmaceutical medicine.

Joseph Kannarkat, MD

Degree Program: Internal Medicine Resident

Dr. Joseph Kannarkat is an internal medicine resident. He has previously published articles on drug regulatory and health policy in venues like The New England Journal of Medicine, The Journal of the American Medical Association, and The Brookings Institution. His research interests include studying the regulation, use, and reimbursement of therapeutics and the role of regulatory agencies (i.e., FDA and CMS) in these processes. Prior to his medical training, he worked with England’s National Health Service in Cambridgeshire to study health system restructuring and explored innovative approaches to healthcare provision in Kenya. He received an MPhil in Public Policy as a Kanders Churchill Scholar at the University of Cambridge and a Master of Global Affairs at Tsinghua University as a Schwarzman Scholar. Joseph completed his undergraduate education in economics and neuroscience at the University of Pittsburgh.

Gbolahan Olatunji, MD, FRSPH

Degree Program: MPH
Research focus: Pharmacoepidemiology of Cardiometabolic disorders; infectious disease and vaccine policy

Gbolahan Olatunji, is a trained physician with over three years of practice and a Fellow of the Royal Society for Public Health. He is an MPH Candidate at the Bloomberg School and a Dean and MPH scholar pursuing the Epidemiology and Biostatistics track. He is an accomplished author with over 90 peer-reviewed publications in international journals; he jointly leads an international research network known as the Emerging Researchers Network which serves to drive more quality research output in Africa. His research has been focused on Cardiovascular health and infectious diseases. Some of his published works include articles on Inclisiran siRNA technology in managing dyslipidemia, the role of semaglutide in heart failure, and Oxford's R21/Matrix-M vaccine, among others. His policy-related articles have also been featured in the Lancet journal. He is particularly interested in learning more about clinical trials in pharmacoepidemiology of novel therapies in cardiometabolic disorders and infectious diseases, as he strives to save lives “millions at a time” and “millions in a lifetime”.

Graduated Scholars

Enoch Abbey, MD, MPH

Degree Program: MPH
Adviser: John Jackson, ScD
Research Focus: Pharmacoepidemiology

Ekta Agarwal, MPH

Degree Program: MPH
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Drug Safety and Adherence

Taiwo Akindahunsi, MD, MPH

Degree Program: MPH (Epidemiology)
Adviser: Sabina Haberleen, PhD
Research Focus: Pharmacoepidemiology, Clinical Trials and Drug Safety and Surgical Outcomes in Neurosurgery

Kayte Andersen, MSc

Degree Program: PhD (Epidemiology)
Adviser: G. Caleb Alexander, MD, MS & Jodi Segal, MD, MPH
Research Focus: Use Beyond the Evidence Base: An Evaluation of Pharmacotherapy During COVID-19

Shirin Ardeshirrouhanifard, PharmD, MPH, PhD

​​​​​​​Degree Program: Postdoctoral Fellow
Adviser: Hemalkumar Mehta, PhD & Jodi Segal, MD, MPH
Research Focus: Safety and effectiveness of medications in cancer population

Melat Asebot, MD, MPH

Degree Program: MPH 
Research Focus: Pharmacoepidemiology, Clinical Trials, Drug Safety and Effectiveness

Samuel Kwakye Ayeh, MBChB (MD), MPH

Degree Program: MPH
Adviser: Jonathan Golub, PhD
Research Focus: Risk factors associated with positive latent tuberculosis test in pregnant women

Sheriza Baksh, PhD, MPH

Degree Program: PhD (Epidemiology)
Adviser: G. Caleb Alexander, MD, MS & Stephen Ehrhardt, MD
Research Focus: Pharmacoepidemiology

Daniah Basodan, MBBS, FRCPC

Degree program: MPH
Adviser: Mara McAdams DeMarco, PhD, MS

Chelsea Canan, MPH, PhD

Degree Program: PhD (Epidemiology)
Adviser: Bryan Lau, PhD
Research Focus: Epidemiologic Methods; Prescription Opioid Misuse

Jessica Chasler, PharmD, BCPS 

Degree Program: MPH
Adviser: Jodi Segal, MD, MPH
Research Focus: Pharmacoepidemiology

Lian-Yu Chen, MD, PhD

Degree Program: PhD (Mental Health)
Adviser: Ramin Mojtabai, MD, PhD
Research Focus: Substance Use Disorders, Service Utilization and Psychiatric Comorbidities

Audrey Cheng, MPH

Degree Program: MPH 
Research Focus: Pharmaceutical policy and law

Francine Chingcuanco, MHS

Degree Program: MHS (Epidemiology)
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Utilization of Generic Medicines

Stacy Elder Dalpoas, PharmD, MPH, BCPS

Degree Program: MPH
Adviser: Jodi Segal, MD, MPH

Matthew Daubresse, MHS

Degree Program: DrPH (Epidemiology)
Adviser: Mara McAdams Demarco, PhD, MS
Research Focus: Impact of Policy Interventions on the Utilization of Prescribed Controlled Substances

Mindi DePaola, MSPH

Degree Program: MSPH (International Health)
Adviser: Victoria B. Chou, PhD, MS
Research Focus: Drug Utilization and Access in Underserved Populations

Leigh Efird, PharmD, MPH, BCPS

Degree Program: MPH
Adviser: Sherita Hill Golden, MD, MHS
Research Focus: Hospital Drug Utilization

Ijeamaka Ezebilo, MD, MPH

Degree Program: MPH
Adviser:  Jodi Segal, MD, MPH
Research Focus: Pharmacoepidemiology

Busola Fadojutimi, B. Pharm, MPH, MBA

Degree program: MPH/MBA
Adviser: Stefan Baral, MD & David Chin, MD, MBA 
Research Focus: Disease epidemiology, drug safety and adverse drug reactions

Kevin Fain, DrPH, JD, MPH

Degree Program: DrPH (Epidemiology)
Adviser: Carlos Castillo-Salgado, MD, DrPH, JD
Research Focus: Safety of Opioid Use in the Elderly

Haley Gibbs, PharmD, MPH, BCPS

Degree Program: MPH
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Therapeutic Drug Monitoring

Gillian Gresham, MSc, PhD

Degree Program: PhD (Epidemiology)
Adviser: Kay Dickersin, PhD
Research Focus: Clinical Trials and Evidence Synthesis

Mengdong He, MHS

Degree Program: MHS (Epidemiology)
Adviser: Edgar R. Miller, MD, PhD
Research Focus: Drug Utilization and Effects

Catherine Hwang, MSPH

Degree Program: MSPH (International Health)
Adviser: G. Caleb Alexander, MD, MS
Research Focus:Prescription Drug Utilization and Abuse-Deterrent Formulations

Geetha Iyer, MBBS, MD, ScM

Degree Program: ScM (Epidemiology)
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Drug Utilization and Pharmacovigilance

Myles Jackson, MHS

Degree program: MHS (Epidemiology)
Research Focus: Pharmacoepidemiology, comparative effectiveness, drug safety

Shiyin Jiao, MHS

Degree Program: MHS (Epidemiology)
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Quality of Pharmaceutical Care, Patient Outcomes, Structure of Clinical Practice

Sindhura Karlapudi, MBBS, MPH

Degree program: MPH
Adviser: G. Caleb Alexander, MD, MS

Taruja Karmarkar, MHS, PhD

Degree Program: PhD (Health Policy and Management)
Adviser: Darrel J. Gaskin, PhD
Research Focus: Pharmacoeconomics, Decision Modeling, Pharmaceutical Policy, and Patient Outcomes Research

Christopher Kaufmann, PhD, MHS

Degree Program: PhD (Mental Health)
Advisers: Ramin Mojtabai, MD, PhD & Adam Spira, PhD
Research Focus: Sedative-Hypnotic Use Among the Elderly

Shelby Kemper, PharmD, MPH

Degree Program: MPH
Adviser: Jodi Segal, MD, MPH
Research Focus: Quality, Access, Availability and Utilization of Pharmaceuticals in Low and Middle Income Countries

Jeongmin (Hana) Kim, PharmD, ScM

Degree Program: ScM (Epidemiology)
Adviser: Jodi Segal, MD, MPH
Research Interests: Pharmacovigilance, signal detection, drug risk/benefit evaluation, post-marketing surveillance, real-world evidence

Martha Tushemereirwe Kirabo, MD, MPH

Degree Program: MPH
Adviser: Janet Holbrook, PhD

Zaina Kiragu, MPharm, MPH

Degree Program: MPH
Adviser: Alain K. Koffi, MD, PhD

Kimberley Lee, MD, MHS

Degree Program: MHS (Epidemiology)
Adviser: Jodi Segal, MD, MPH
Research Focus: Pharmacoepidemiology

Seoyoung (Celina) Lee

Degree Program: MSPH (Health Policy & Management)

Shanshan Lin, ScM

DEGREE PROGRAM: SCM (EPIDEMIOLOGY)
ADVISER: CALEB ALEXANDER, MD, MS & JODI SEGAL, MD, MPH
RESEARCH INTERESTS: PHARMACOEPIDEMIOLOGY, REAL-WORLD EVIDENCE

Yi-Chen Liu, MHS

Degree Program: MHS (Epidemiology)
Adviser: Mara McAdams Demarco, PhD, MS
Research Focus: Pharmacoepidemiology

Xintong Li, BSc

Degree Program: MHS (Epidemiology)
Adviser:  G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, drug safety, effectiveness and utilization

Eleanor Lucas, BA

Degree Program: MPH
Adviser: Aditi P. Sen, PhD

Nune Makarova, MD, MPH

Degree Program: MPH
Adviser: Debra Roter, DrPH, Professor

Omar Mansour, MHS

Degree Program: MHS (Epidemiology)
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Drug Utilization

Sathiya Priya Marimuthu, MBBS, MHS

Degree Program: MHS 
Advisers: Brent Petty, MD & Jodi Segal, MD, MPH
Research Focus: Drug Safety and Pharmacoepidemiology

Kathryn Marwitz, PharmD, MPH

Degree Program: MPH 
Adviser: Jodi Segal, MD, MPH
Research Focus: Pharmacoepidemiology and Pharmaceutical Policy

Morgan Maziarz, MHS

Degree Program: MHS (Epidemiology)
Adviser: Ann-Margaret Ervin, PhD
Research Focus: Pharmacoepidemiology, drug utilization, clinical trials

Yidnekachew Mogessie, MD, MPH, MBA

Degree Program: MPH-MBA, Certificate in Pharmacoepidemiology and Clinical Trials
Research Focus: Pharmacoepidemiology, clinical trials, health economics and outcomes research, surgical outcomes research

Alexander Moran, MSPH

Degree Program: MSPH (Department of International Health)
Adviser: Lawrence Moulton, PhD
Research Focus: Drug Utilization and Adherence

Morgane Mouslim, DVM, ScM

Degree Program: ScM (Epidemiology)
Adviser: Jodi Segal, MD, MPH & G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology

Joelynn Muwanga, MPH

Degree Program: MPH
Research interests: Drug utilization, effectiveness, safety and medication adherence

Remington Nevin, DrPH, MD, MPH

Postdoctoral Fellow (Occupational Medicine Residency Program, Department of Environmental Health Sciences)
Adviser: Francesca Litow, MD, MPH
Research focus: Occupational Drug Safety and Pharmacovigilance

Richard Dunku Nudotor, MB CHB, MPH

Degree Program: MPH
Adviser: Mara McAdams DeMarco, PhD, MS
Research Focus: Clinical Trials, Pharmacoepidemiology and Drug Safety, Surgical Outcomes in Pancreatic and Bariatric Surgery

Ken Ogasawara, PhD, MPH

Degree Program: MPH
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Regulatory Science

Gaurvika ML Nayyar, MPH, MBA

Degree Program: MPH & MBA
Adviser: David Peters, MD, DrPH, MPH
Research focus: Pharmaceutical Quality, Emerging Markets, Health Outcomes, and Access

David Procaccini, PharmD, BCPS, CACP

Degree Program: MPH
Adviser: Gerard Anderson, PhD
Research Focus: Health Policy and Medication Safety in Pediatric Population

Yao (Lucy) Qiao, MPH, MSc, PhD

Degree Program: PhD (Epidemiology)
Advisers: G. Caleb Alexander, MD, MS & John W. Jackson, ScD
Research Focus: Pharmacoepidemiology

Emaan Rashidi, MHS

Degree Program: MHS (Epidemiology)
Adviser: Stephan Ehrhardt, MD
Research Focus: Pharmacoepidemiology & Psychiatric Epidemiology

Kevin Riggs, MD, MPH

Adviser: G. Caleb Alexander, MD, MS
Research focus: Prescription Drug Costs

Michelle Robinson, PharmD, MPH

Degree Program: MPH
Adviser: Jill Marsteller, PhD
Research Focus: Drug utilization, public health policy, medication safety

Cindy Sagoe, BPharm, MPH

Degree Program: MPH
Adviser: Irene Murimi, PhD

Marissa Seamans, PhD, MSPH

Degree Program: Postdoctoral Fellow (Mental Health)
Adviser: Elizabeth Stuart, PhD
Research Focus: Household Patterns of Prescription Medication Use

Alex Secora, MPH, PhD

Degree Program: PhD (Epidemiology)
Advisers: G. Caleb Alexander, MD, MS & Josef Coresh, MD
Research Focus: Pharmacoepidemiology

Ashton Shaffer

Degree Program: MD-PhD (Epidemiology)
Adviser: Mara McAdams Demarco, PhD, MS
Research Focus: HIV+ Liver Transplant Candidates and Recipients

Mariana Socal, MD, MSc, MPP, PhD

Degree Program: PhD (Department of Mental Health)
Adviser: Antonio Trujillo, MPP, PhD
Research focus: Pharmaceutical Access and Utilization in Low- and Middle-Income Countries

Jingwen Tan, PhD, ScM

Advisers: G. Caleb Alexander, MD, MS & Jodi B. Segal, MD, MPH
Research focus: Epidemiology of Drug-Induced Morbidity and Mortality

Sangeeta Tandon, PharmD, MPH

Degree Program: MPH
Adviser: Andrea Ruff, MD
Research Focus: Pharmaceutical Quality, Access, and Affordability in Low Income Countries

Sarah Tanveer, MA

Degree Program: MA (Public Health Biology)
Advisers: Barry Zirkin, PhD & G. Caleb Alexander, MD, MS
Research Focus: Migraine/Headache disorders, Evidence Synthesis, Comparative Effectiveness Research, Pharmacoepidemiology

Rediet Tekalign, MD, MPH

Degree Program: MPH
Research Focus: Pharmacoepidemiology, clinical trials, biologic drug safety, effectiveness in pediatrics

Carolyn Tieu, PharmD, MPH

Degree Program: MPH
Adviser: G. Caleb Alexander, MD, MS
Research focus: Pharmacoepidemiology, Comparative Effectiveness Research, Patient Outcomes Research 

Phuong Tran, PharmD, MPH

Degree Program: MPH
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Cancer Epidemiology, Genetics and Epigenetics

Chinenye Ugoji, BPharm, MPH, PhD

Degree Program: PhD (Epidemiology)
Advisers: Elizabeth Platz, ScD & Lorraine Dean, ScD
Research Focus: Pharmacoepidemiology, Cancer, HIV, Outcomes research

Siddhi Umarje, PharmD

Degree Program: ScM
Adviser: Catherine Sutcliffe, PhD

Shilpa Viswanathan, PhD, MS, BPharm

Degree Program: PhD (Epidemiology)
Adviser: Lisa P. Jacobson, ScD
Research Focus: Effects of Concomitant Medication Use on Adherence to Highly Active Antiretroviral Therapy (HAART)

Amelia Wallace, MS 

Degree Program: PhD (Epidemiology)
Adviser: Elizabeth Selvin, PhD, MPH & Morgan Grams, MD, PhD
Research Focus: Pharmacoepidemiology

Jiajun Wen, MD, MPH, ScD

Degree Program: ScD (Epidemiology)
Adviser: Janet Holbrook, PhD, MPH, MS
Research Focus: Pharmacoepidemiology and Clinical Trials

Xuya Xiao, MHS

Degree Program: MHS (Epidemiology)
Adviser: Caleb Alexander, MD, MS & Hemalkumar Mehta, PhD
Research Focus: Pharmacoepidemiology, drug safety, drug utilization

Yunwen Xu, MHS

Degree Program: MHS
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Drug Utilization, Outcomes Research

Jeffrey Yu, MHS

Degree Program: MHS (Department of Health Policy & Management)
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoeconomics, Pharmacoepidemiology, Pharmaceutical Policy, Decision Modeling

Hanzhe Zhang, MHS

Degree Program: MHS (Epidemiology)
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology

Meijia Zhou, MHS

Degree Program: MHS
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Drug Utilization and Safety

Fasika Molla Abreha, MD, MPH

Degree Program: MPH
Research Focus: Pharmacoepidemiology, Drug Access, Safety and Effectiveness

Allie Babyak, MHS

Degree Program: MHS (Health Economics and Outcomes Research)
Advisor: Jeromie Ballreich, MHS, PHD
Research Focus: Pharmaceutical policy, pharmacoeconomics

Umaima Tahir Banda, BSc, MPH

Degree Program: MPH (Epidemiology/Biostatistics)
Research Focus: Pharmacoepidemiology, Safety and effectiveness of vaccines and biologics

Cheryl Chia, PhD, MPH/MBA

Degree program: MPH/MBA
Advisor: G. Caleb Alexander, MD, MS
Research Focus: Public health policy and pharmacoeconomics

Michael Chiu, ScM

Degree program: ScM (Epidemiology)

Sanika Chivate, MHS

Degree program: MHS (Epidemiology)
Research Focus: Infectious disease epidemiology and pharmacoepidemiology

Grace Gahlon, ScM

Degree program: ScM (Epidemiology)
Research Focus: Class II and III medical devices, real-world evidence, regulatory science

Scott Goldman, MPH/MBA

Degree program: MPH/MBA
Advisor: Matthew D. Eisenberg, PhD

Shota Hasui, MA, MPH

Degree program: MPH (Epidemiology/Biostatistics)
Research Focus: Pharmacoeconomics, Real World Evidence, Comparative Effectiveness, Health Technology Assessments, Meta-research/Critical Appraisal

Jamie Heyward, MPH, PhD

Degree program: PhD (Epidemiology)
Advisors: Jodi Segal, MD, MPH & Hemalkumar Mehta, PhD
Research focus: Pharmacoepidemiology, regulatory science

Ozi Iyalomhe, MPH

Degree Program: MPH
Advisor: Jung-Im Shin, MD, PhD
Research Focus: Pharmacoepidemiology, drug utilization

Kyungah Kim, PharmD, MPH

Degree Program: MPH
Advisor: Ann-Margret Ervin, PhD, MPH

Gauri Kore, MBBS

Degree Program: ScM (Epidemiology)
Advisor: Shruti Mehta, PhD
Research Interests: Infectious disease epidemiology, pharmacoepidemiology

Lipin Lukose, PharmD, MPH

Degree Program: MPH
Research Interests: Pharmacoepidemiology, Medication Access and Safety

Kriti Rastogi, MHS

Degree Program: MHS (Mental Health)
Advisor: Jeanine Parisi, PhD, MA & Elise Weerts, PhD
Research Focus: Behavioral pharmacology of alcohol, substance use in underserved populations

Rupshikha Sen, MHS

Degree Program: MHS (Epidemiology)
Advisor: Keri Althoff, MPH, PhD

Biruk Teshome, MD, MSc, MPH

Degree Program: MPH
Advisor: Yvonne Commodore-Mensah, PhD, MHS

Astha Wahi, BDS, MBA, ScM

Degree Program: ScM (Epidemiology)
Advisor: Catherine Sutcliffe, PhD, Maria Deloria Knoll, PhD
Research Focus: Infectious disease epidemiology, pharmacoepidemiology, vaccine science and policy, real-world evidence use

Daniel Willie-Permor, MD, MPH

Degree Program: MPH
Advisor: Conan Dickson, PhD
Research Focus: Artificial intelligence and machine learning in the drug discovery/manufacturing processes

Ziang (Bill) Zhou, BS, MHS

Degree Program: MHS (Epidemiology)
Advisor: Hemalkumar Mehta, PhD
Research Focus: Drug-drug interactions for concomitant use of DOACs and statins